Anthony S. Marucci, born on July 1, 1972, holds an MBA from the Wharton School at the University of Pennsylvania and a Biology degree from the same university. He has been at the helm of Celldex Therapeutics, Inc. since 2013,...

Anthony S. Marucci, born on July 1, 1972, holds an MBA from the Wharton School at the University of Pennsylvania and a Biology degree from the same university. He has been at the helm of Celldex Therapeutics, Inc. since 2013, overseeing its advancements in biotechnology. Under his leadership, the company has made significant strides in clinical trials and the regulatory approval process. His compensation reflects the company's performance; in 2021, he earned about $1.17 million, with a substantial part coming from stock options and bonuses. Notably, he was awarded 224,000 stock options in 2021 to boost corporate goals. Marucci's past experience includes serving as Executive Vice President of Corporate Development at AVANT Immunotherapeutics. He's been through ups and downs in the biotech space but has maintained a steady focus on achieving corporate objectives related to pipeline development. He keeps a significant portion of his wealth tied up in Celldex's stock, aligning his interests with shareholders.